scholarly journals The Influence of Corpus Luteum Size on the Conception in Embryo Transfer Recipient Cows

Author(s):  
Erkan SAY ◽  
Mehmet Ferit ÖZMEN ◽  
Hakan SAĞIRKAYA
2016 ◽  
Vol 28 (2) ◽  
pp. 184
Author(s):  
M. Pelizzari ◽  
A. Tribulo ◽  
J. Garzon ◽  
B. Bernal ◽  
R. Tribulo ◽  
...  

A retrospective analysis of factors that affect pregnancy rates from 4214 fresh in vitro-produced (IVP) embryos that were transferred at a fixed-time (FTET) in 20 different farms. Recipients were all cycling cows or heifers that were synchronized with 1 of 3 treatments: 1) treatments with progesterone (P4) devices and 2 mg of oestradiol benzoate (EB) on Day 0 (day of insertion) and 24 h after device removal (Day 8); 2) treatments with P4 devices and EB on Day 0, but with 0.5 mg of oestradiol cypionate (ECP) at device removal (Day 8); or 3) treatments with P4 devices and GnRH on Day 0 and a second GnRH 60 h after device removal (Day 5). Cows in all treatment groups also received 500 µg of cloprostenol (prostaglandin F2α) at the time of P4 device removal and 400 IU of eCG either at device removal or 3 days before device removal. All embryos were transferred 7 or 8 days after the expected time of oestrus (24 h after EB, 48 h after ECP or at the time of the second GNRH for each synchronization treatment, respectively). On the day of embryo transfer, recipients were examined by ultrasonography and those with corpus luteum >14 mm in diameter received a fresh, IVP embryo in the uterine horn ipsilateral to the corpus luteum. Pregnancy rates were determined by ultrasonography 35 days after FTET. Data were analysed by logistic regression. Independent variables were classified into the following three categories. 1) Factors related to the recipient and the environment; there were no significant differences in pregnancy rates for corpus luteum diameter (≥14 and <16 mm, ≥16 and <18 mm, or ≥18 mm; P = 0.46), number of corpus luteum (1 or ≥2; P = 0.26), and category of recipient (cow or heifer; P = 0.21). However, there were significant effects of farm (P = 0.01) and body condition score (BCS; P = 0.01). Cows with BCS ≥4.5 (1 to 5 scale) resulted in lower pregnancy rates (4/20, 20.0%) than those with BCS 2 (74/225, 32.9%), 2.5 (502/1434, 35.0%), 3 (570/1467, 38.9%), 3.5 (193/532, 36.3%), and 4 (44/118, 37.3%). 2) Factors related to the synchronization treatment; there were no significant differences between recipients receiving eCG at device removal (84/209, 40.2%) or 3 days before device removal (874/2291, 38.1%; P = 0.35). However, recipients synchronized with P4 devices and ECP had higher (P = 0.01) pregnancy rates (232/483, 48.0%) than those treated with EB (679/1888, 36.0%) or gonadotropin-releasing hormone (47/129, 36.4%). 3) Factors related to the embryo transfer technique; day of the recipient’s oestrous cycle (P = 0.36), stage of embryo transferred (IETS stages 6 or 7; P = 0.62), and operator (P = 0.57) did not affect pregnancy rates. However transfers made in the anterior third of the uterine horn resulted in higher (649/1545, 42.0%) pregnancy rates than those in the mid-third (845/2511, 33.6%) or in the distal third (6/35, 17.1%; P = 0.01). It was concluded that factors related to the recipient and the environment (farm and BCS), the synchronization treatment (ECP), and the embryo transfer technique (site of deposition) affect pregnancy rates in recipients of embryos produced in vitro and transferred at a fixed time.


2012 ◽  
Vol 24 (1) ◽  
pp. 167
Author(s):  
A. Shirasawa ◽  
Y. Nakamura ◽  
A. Ideta ◽  
Y. Oono ◽  
M. Urakawa ◽  
...  

Recipient animals for bovine embryo transfer (ET) are routinely selected according to the morphology of the corpus luteum (CL) estimated by rectal palpation. However, rectal palpation is not a precise method of diagnosing the functional status of a CL. Ovarian ultrasonography (US) may be used to improve such diagnoses. The aim of this study was to evaluate the relationship between ultrasonographic images of CL and pregnancy rates after ET in Holstein heifers to determine whether US can be used to select recipients for ET. Recipient heifers (n = 285) were selected by detection of natural oestrus or following oestrus synchronization using a progesterone-releasing intravaginal device (PRID; ASKA Pharmaceutical, Tokyo, Japan). Transrectal US was performed immediately before ET, on Days 6 to 8 of the oestrous cycle (oestrus = Day 0), using a B-mode scanner (HS1500V; Honda Electronics Co. LTD, Aichi, Japan) equipped with a 7.5-MHz linear-array transducer designed for intrarectal placement. A cross-sectional image of the maximal area of the CL and luteal cavity was obtained. The areas of the CL and luteal cavity were each calculated using the formula for the area of an ellipse (height/2 × width/2 × π). (1) Ultrasonic morphology of CL was classified into 3 types: without cavity (n = 128), with cavity (n = 145) and with blood clot (n = 12). (2) The luteal cavity was categorized into 3 groups: small (<100 mm2, n = 93), medium (100 ≤ x < 200 mm2, n = 32) and large (≥200 mm2, n = 20). (3) Luteinized tissue area (total area of CL minus the area of the luteal cavity) was categorized into 3 groups: small (<250 mm2, n = 61), medium (250 ≤ x < 350 mm2, n = 128) and large (≥350 mm2, n = 84). In vivo–produced embryos were transferred nonsurgically into the uterine horn ipsilateral to the CL. Pregnancy was determined by transrectal US on Days 30 to 40 of gestation. The pregnancy rates of each experimental group were analysed by logistic regression. In this study, the pregnancy rate did not differ significantly in each experimental group: (1) without cavity: 77.3% (99/128), with cavity: 75.2% (109/145) and blood clot: 75.0% (9/12); (2) small cavity: 73.1% (68/93), medium: 75.0% (24/32) and large: 85.0% (17/20). The mean area of the cavity was 100.8 ± 110.3 mm2 (mean ± standard deviation) and recipients with 0 to 539.7 mm2 sized cavities had successful pregnancies (observational range was 0 to 539.7 mm2). (3) The pregnancy rates of recipients that had small, medium and large luteinized tissue were 77.0% (47/61), 75.0% (96/128) and 77.4% (65/84), respectively. The mean area of luteinized tissue was 318.9 ± 90.3 mm2 and 155.0 to 620.0 mm2 sized luteinized tissue had pregnancy success (observational range was 132.8 to 620.0 mm2). In conclusion, the results from this study indicate that the presence of a luteal cavity or blood clot has no detrimental effect on pregnancy success after ET in Holstein heifers. Furthermore, no relationship was found between luteinized tissue area at the time of ET and pregnancy rate.


2013 ◽  
Vol 25 (1) ◽  
pp. 229
Author(s):  
J. W. Thorne ◽  
C. R. Looney ◽  
J. F. Hasler ◽  
D. K. Hockley ◽  
D. W. Forrest

This study was performed to test the viability of administering Folltropin-V® (FSH, Bioniche Animal Health) diluted in hyaluronan (MAP-5 50 mg, sodium hyaluronate, Bioniche Animal Health) to beef cows enrolled in a recipient synchronization protocol to evaluate its effect on recipient fertility. All recipients were administered an estradiol 17β (2.5 mg, IM) and progesterone (50 mg, IM) combination injection on Day 0, a CIDR® (progesterone 1.34 g, Pfizer Animal Health, Groton, CT, USA) was inserted for 7 days. Lutalyse® (dinoprost tromethamine, Pfizer Animal Health, 25 mg, IM) was administered at the time of CIDR removal on Day 7, and estradiol 17β (1 mg, IM) was administered on Day 8. On Day 16, the presence of at least one corpus luteum, detected via ultrasound, resulted in the recipient receiving an embryo (both fresh and frozen–thawed embryos were used). Embryos were not transferred into cows that did not show ultrasonic evidence of a CL. Dependent variables for which data were collected included circulating progesterone levels at the time of transfer and CL diameter, area, and circumference; measured in millimeters. The total study (n = 274) consisted of both wet (n = 85) and dry (n = 189) cows and included both Bos indicus (Brahman-influenced) crossbred (n = 93) and Bos taurus (Angus-based) cows (n = 181). The experiment consisted of cows being placed in either the treated or control groups, with treated cows receiving a single 40 mg (1 mL) IM injection of Folltropin-V in hyaluronan on Day 5 and control cows receiving no additional injections. Results are shown in Table 1. Transfer rate, conception rate, and pregnancy rate were tested for significance with chi-square analysis and remaining statistics were analyzed with a t-test: two-sample assuming equal variances. There were no significant differences found between the treated and control groups for transfer rate, conception rate, or pregnancy rate. Corpus luteum diameter was shown to be larger in control cows (P < 0.05); however, CL area and circumference did not differ significantly. Folltropin-V given with hyaluronan at a 40-mg dose on Day 5 did not improve fertility, induce a larger CL, or increase circulating progesterone levels in synchronized beef recipients as hypothesized. Further work is needed with Folltropin-V in hyaluronan to determine if an alternative dose or timing of administration would be more appropriate for improving fertility in recipients. Table 1.Fertility data in beef recipients following synchronization for fixed-time embryo transfer with a protocol that included (Treated) or did not include (Control) FSH in hyaluronan


2009 ◽  
Vol 72 (7) ◽  
pp. 949-958 ◽  
Author(s):  
L.G.B. Siqueira ◽  
C.A.A. Torres ◽  
E.D. Souza ◽  
P.L.J. Monteiro ◽  
E.K.N. Arashiro ◽  
...  

Author(s):  
Robert Setton ◽  
Kelly McCarter ◽  
Lilli D. Zimmerman ◽  
Zev Rosenwaks ◽  
Steven D. Spandorfer

2019 ◽  
Author(s):  
Omar Sefrioui ◽  
Aicha Madkour ◽  
Nouzha Bouamoud ◽  
Ismail Kaarouch ◽  
Brahim Saadani ◽  
...  

AbstractImmunotherapy using PBMC administration demonstrated relatively its effectiveness to treat RIF patients but it still unclear to explain some miscarriages. Luteal progesterone level (LPL) issued from corpus luteum after embryo implantation stage could be informative basis data to personalize immunotherapy for RIF patients predicting clinical outcomes. This randomized controlled study included 70 patients undergoing ICSI program presenting at least 3 RIF: 39 for Control of untreated patients and 31 for PBMC-test concerning treated patients with immunotherapy. For PBMC-test group, Peripheral Blood Mononuclear Cells (PBMCs) were isolated from patients on ovulation induction day and cultured three days to be administered to intrauterine cavity of patients two days before fresh embryo transfer. LPL was analyzed at day 15 after embryo transfer and clinical outcomes were calculated including implantation, clinical pregnancy and miscarriage rates. Clinical outcomes were doubly improved after immunotherapy including implantation and clinical pregnancy rates comparing Control versus PBMC-test (10% and 21% vs 24% and 45%). In the other hand, this strategy showed an increase over double in LPL (4ng/ml for Control vs 9ng/ml for PBMC-test) while the latter was correlated to clinical pregnancy. Bypassing the effectiveness of this immunotherapy approach for RIF patients, it is directly correlated to LPL proving the interactive reaction between immune profile of the treated patients and progesterone synthesis by corpus luteum.


2019 ◽  
Vol 03 (01) ◽  
pp. 43-49
Author(s):  
Zijing Zhang ◽  
Weigang Liu ◽  
Wenyi Lu ◽  
Shibao Song ◽  
Jie Pi

2020 ◽  
Vol 32 (2) ◽  
pp. 176
Author(s):  
M. K. Sermersheim ◽  
B. R. Lindsey ◽  
L. M. Naves ◽  
M. Rubessa ◽  
M. B. Wheeler

The advent of colour Doppler ultrasound has allowed evaluation of blood flow to bodily tissues. This novel technology is being tested as a tool to improve efficiency in a variety of livestock reproduction programs. The objective of the present study was to evaluate the relationship between blood flow to the ovarian corpus luteum (CL), imaged via colour Doppler ultrasound, and pregnancy rate in crossbred dairy recipients for embryo transfer (ET). Oestrous cycles of Bos indicus×Bos taurus dairy heifers (n=90, 16-24 months of age) were synchronized for embryo transfer on Days 7-8. Immediately before ET, heifers were palpated for the presence of ovarian CL and CL papillae. Presence of CL, CL papillae, and CL lacunae were confirmed via transrectal B-mode ultrasound (Ibex EVO I, E. I. Medical Imaging). Transrectal colour Doppler ultrasound (Ibex EVO I, E. I. Medical Imaging) was used to evaluate blood flow to the CL. Invitro-produced (IVP) blastocysts (qualities I and II) were transferred to the uterine horn ipsilateral to the CL. All palpation, imaging, and embryo transfer was performed by a single technician. Pregnancy was determined via transrectal ultrasound 24-32 days post-embryo transfer (31-39 days of embryo age). Blood flow to the CL was split into three categories: high, median, and low. Presence or absence of two additional CL structures, CL papillae and lacunae, were recorded. Fisher's exact test was used to evaluate data. Statistical differences were considered significant at P&lt;0.05. The overall pregnancy rate was determined to be 40%, 36 out of 90. Pregnancy rates were similar in high (33.9%, 20 of 59), median (59.09%, 13 of 22), and low (33.33%, 3 of 9) blood flow categories. Consistent with previous studies, absence of CL papillae and presence of CL lacunae at the time of ET did not affect pregnancy rate. Doppler blood flow, papillae, and lacunae were also evaluated together in each possible combination. Only one outlier was present; all other differences were not significant. The highest pregnancy rate (66.67%, 10 of 15) was observed in recipients with CLs with median Doppler blood flow, a palpable CL papillae, and no CL lacunae. A larger sample size is required to determine the accuracy of this measurement. In conclusion, recipients with high to low CL blood flow are suitable for IVP embryo transfer programs. Alone, colour Doppler imaging of the CL does not predict pregnancy rate.


Sign in / Sign up

Export Citation Format

Share Document